MYELOVAX
Live / Registered — Registered (as of 14 Jan 2025)
What this means for you
Registered since 14 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97722425
- Registration number
- 7655180
- Mark type
- Stylized text
- Filed
- 19 Dec 2022
- Published for opposition
- 31 Oct 2023
- Registered
- 14 Jan 2025
- Attorney of record
- Mark David Torche
Goods and services
- Class 005 — Pharmaceuticals: Human vaccine preparations; Therapeutic vaccines; Vaccine preparations; Vaccines; Veterinary vaccines
Owner
- Meridian Therapeutics Inc., Lehi,, UT, US
- Meridian Therapeutics Inc., Lehi,, UT, US
- Meridian Therapeutics Inc., Lehi,, UT, US
Prosecution history
- 14 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 20 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Nov 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2024 — USE AMENDMENT FILED
- 21 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 21 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2024 — SOU EXTENSION 1 GRANTED
- 26 Jun 2024 — SOU EXTENSION 1 FILED
- 20 Aug 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 27 Jun 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION